Ventilator-associated pneumonia in an Italian pediatric intensive care unit: a prospective study

Maria Francesca Patria1, Giovanna Chidini, Ludovica Ughi

  • 1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Insights

Ventilator-associated pneumonia (VAP) affects 6.6% of pediatric intensive care unit patients, increasing hospital stay and mortality. Risk factors include re-intubation, tracheostomy, and enteral feeding.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease epidemiology
  • Mechanical ventilation

Background:

  • Ventilator-associated pneumonia (VAP) is a significant concern in pediatric intensive care units (PICUs).
  • Understanding VAP prevalence, risk factors, and outcomes is crucial for improving patient care.

Purpose of the Study:

  • To determine the prevalence of VAP in a European PICU.
  • To identify risk factors associated with VAP development.
  • To analyze the outcomes of VAP in mechanically ventilated children.

Main Methods:

  • Prospective study enrolling 451 children mechanically ventilated for ≥ 48 hours.
  • Data collected over a 3-year period in a European PICU.
  • Statistical analysis, including logistic regression, to identify risk factors.

Main Results:

  • VAP prevalence was 6.6% (30 children).
  • Children with VAP experienced significantly longer PICU and hospital stays (P<0.0001).
  • Independent risk factors for VAP included re-intubation (P=0.0001), tracheostomy (P=0.04), and enteral feeding (P=0.02).
  • VAP was associated with a higher mortality rate (P=0.04).

Conclusions:

  • A notable proportion of intubated children develop VAP, linked to invasive procedures.
  • VAP significantly increases healthcare costs and mortality.
  • Multicenter studies are essential to enhance VAP prevention and treatment strategies.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
58
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
1.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
773